WHO WE ARE

FODIAC assembles a European multi/interdisciplinary consortium, composed of partners in 5 countries that provide expertise in: extraction and purification of bioactive molecules, nanotechnology, nano/micro-encapsulation, toxicology, nutrition, biomarkers and clinical trial management.

TOGETHER WE FIGHT DIABETES

The overall R&I objective of FODIAC is to develop an integrative dietary solution to tackle diabetes and the associated impairment of the cognitive function among the elderly by the development of bioactive ingredients, and functional foods and diets.

This is achieved through an advanced international, intersectoral, cooperation between 7 academic and 8 non-academic partners.

FODIAC builds on BiValBi FP7-IRSES results, a successful project where the team was already responsible for gaining knowledge in the recovery of bioactive compounds from food wastes, and the encapsulation of those compounds for food applications. FODIAC will go further, by focusing on understand how dietary intervention strategies using an appropriate combination of foods containing functional ingredients (polyphenols) with proven bioactivity can be used to reduce Type 2 diabetes (T2D) and mitigate the decay of cognitive function among the elderly.